Related references
Note: Only part of the references are listed.Enhanced Retention and Cellular Uptake of Nanoparticles in Tumors by Controlling Their Aggregation Behavior
Xiangsheng Liu et al.
ACS NANO (2013)
Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells
Ming-Ying Lan et al.
AURIS NASUS LARYNX (2013)
Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers
Rajaletchumy Veloo Kutty et al.
BIOMATERIALS (2013)
Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model
Hao-Wen Kao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation
Shyhmin Huang et al.
CANCER RESEARCH (2013)
PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties
Manu M. Joseph et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Injectable nanomaterials for drug delivery: Carriers, targeting moieties, and therapeutics
David M. Webster et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
The anticancer properties of iron core-gold shell nanoparticles in colorectal cancer cells
Ya-Na Wu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Nanometric gold in cancer nanotechnology: current status and future prospect
Mohammad Zaki Ahmad et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
EGFR-directed monoclonal antibodies in non-small cell lung cancer
Robert Pirker
TARGETED ONCOLOGY (2013)
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity
Miyako Takata et al.
CANCER BIOLOGY & THERAPY (2012)
Intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines
Seung-Hee Ryu et al.
LUNG CANCER (2012)
A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer Chemotherapy
Xu Chao et al.
PLOS ONE (2012)
Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer
Linda Leung et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions
J. F. Hainfeld et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
Rebekka Krumbach et al.
EUROPEAN JOURNAL OF CANCER (2011)
Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
Jameel Ahmad Khan et al.
PLOS ONE (2011)
Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non-Small-Cell Lung Cancer
Shirin Khambata-Ford et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Sarah D. Brown et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
Sanjib Bhattacharyya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery
Mani Prabaharan et al.
BIOMATERIALS (2009)
Gold Nanoparticles of Diameter 1.4 nm Trigger Necrosis by Oxidative Stress and Mitochondrial Damage
Yu Pan et al.
SMALL (2009)
Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model
Yu-Hung Chen et al.
MOLECULAR PHARMACEUTICS (2007)
Clinical implications of EGFR expression in the development and progression of solid tumors: Focus on non-small cell lung cancer
David S. Ettinger
ONCOLOGIST (2006)
Antiangiogenic properties of gold nanoparticles
P Mukherjee et al.
CLINICAL CANCER RESEARCH (2005)
Share Paper
